Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.

More than one million donated drugs risk expiring within nine months due to deep cuts in global aid, threatening treatment programmes for neglected tropical diseases in Africa.